Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DEXLANSOPRAZOLE
- Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects.
- Dexlansoprazole MR-Based Concomitant Quadruple Therapy
- A Study to Compare the Bioavailability (BA) of Dexlansoprazole Delayed-release Capsules
- Comparison of the Efficiency of Two Different PPI Formula in Atypical GERD
- The Evaluation of Effectiveness Between Empirical and Guided Therapy for Unexplained Non-Cardiac Chest Pain
- A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese Participants
- Effectiveness of Physiologic Testing in PPI Non-Responders
- Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants
- Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori
- An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan
- A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults (Part 1)
- Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive Esophagitis
- Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients
- Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis
- A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years
- A Phase 2, Double Blind Study to Assess Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Participants
- Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection
- A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)
- Dexlansoprazole MR in Nonerosive Reflux Disease
- Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
- Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease
- Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection
- Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation
- Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets
- Bioavailability, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets in Healthy Participants
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents
- Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents
- Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain
- Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis
- Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy
- Evaluating Treatment Response in Laryngo-Pharyngeal Reflux
- The Effects of Dexlansoprazole for the Treatment of Throat-Related Reflux
- Effect of Dexlansoprazole on Bone Homeostasis
- Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn
- Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?
- Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux Disease
- A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.
- Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy
- Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy
- Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease
- A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn
- Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease
- Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis
- Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn
- Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis
- Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis
- Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn
- Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn
- Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis
- Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis
Clinical trials list
click for details